Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission - Full Text View - ClinicalTrials.gov

Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission

The recruitment status of this study is unknown because the information has not been verified recently.

Verified July 2008 by National Cancer Institute (NCI). Recruitment status was Not yet recruiting

First Received on June 6, 2008. Last Updated on July 27, 2011 History of Changes

Sponsor:	Gynecologic Oncology Group
Collaborator:	National Cancer Institute (NCI)
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00693342